A carregar...

Critical appraisal of the role of rituximab in the treatment of patients with previously untreated or treated chronic lymphocytic leukemia (CLL)

Patients with chronic lymphocytic leukemia (CLL) have benefited from the introduction of targeted therapy for leukemia. Rituximab (a chimeric murine-derived monoclonal antibody that targets CD20 on lymphocytes) was the first monoclonal antibody to affect the natural course of this disease. Several r...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Al-Kali, Aref, Wierda, William, Keating, Michael, O’Brien, Susan
Formato: Artigo
Idioma:Inglês
Publicado em: Dove Medical Press 2010
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3262335/
https://ncbi.nlm.nih.gov/pubmed/22282690
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!